Fineline Cube

Follow:
14422 Articles
MediLink and Zai Lab Collaborate on LRRC15-Targeted ADC Drug ZL-6201
CompanyDeals

MediLink and Zai Lab Collaborate on LRRC15-Targeted ADC Drug ZL-6201

Bayer's Elinzanetant Meets All Primary Endpoints in Phase III OASIS 4 Study
CompanyDrug

Bayer’s Elinzanetant Meets All Primary Endpoints in Phase III OASIS 4 Study

Inmagene Biopharmaceuticals Posts Positive Results for IMG-007 in Atopic Dermatitis
CompanyDrug

Inmagene Biopharmaceuticals Posts Positive Results for IMG-007 in Atopic Dermatitis

BrainAurora Medical Technology IPOs on Hong Kong Stock Exchange
CompanyDeals

BrainAurora Medical Technology IPOs on Hong Kong Stock Exchange

NMPA Releases 89th Batch of Reference Drugs for GQCE Work
Policy / Regulatory

NMPA Releases 89th Batch of Reference Drugs for GQCE Work

China's NHC Aims for Over 90% Child-Friendly Hospitals by 2030
Policy / Regulatory

China’s NHC Aims for Over 90% Child-Friendly Hospitals by 2030

Stryker to Acquire Inari Medical for USD 4.9 Billion to Boost VTE Pipeline
CompanyDeals

Stryker to Acquire Inari Medical for USD 4.9 Billion to Boost VTE Pipeline

GSK Launches Cabotegravir Injection in China for HIV Pre-Exposure Prophylaxis
CompanyDrug

GSK Launches Cabotegravir Injection in China for HIV Pre-Exposure Prophylaxis

Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong
CompanyDeals

Insilico Medicine Raises USD 100 Million in Financing Round Led by Pudong and Hong Kong

Haier Biomedical Terminates Acquisition Plan for Shanghai RAAS
CompanyDeals

Haier Biomedical Terminates Acquisition Plan for Shanghai RAAS

NHSA Revises 2024 NRDL Drug Information Based on Public Feedback
CompanyDrug

NHSA Revises 2024 NRDL Drug Information Based on Public Feedback

Eli Lilly China's Neuroscience VP Jiang Yifei Departs for New Opportunities
Company

Eli Lilly China’s Neuroscience VP Jiang Yifei Departs for New Opportunities